Clinical and Vaccine Trials for Covid-19: Key Considerations from Social Science

Published on 8 October 2020

Previous months have witnessed a growth of clinical research in response to the Covid-19 crisis. This brief sets out social science considerations that can inform clinical and vaccine trials for Covid-19.

It was developed for SSHAP by London School of Hygiene and Tropical Medicine (LSHTM) by Rose Burns, Alex Bowmer, Luisa Enria, Samantha Vanderslott (University of Oxford) and Shelley Lees in order to inform design, recruitment and community engagement, implementation and results dissemination for trials of emerging vaccine and therapeutic candidates for Covid-19. Colleagues from Dalhousie University and Kings college London reviewed it.

Cite this publication

SSHAP (2020) Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science (October 2020), SSHAP

Citation copied


Rose Burns

Luisa Enria

Alex Bowmer

Samantha Vanderslott

Shelley Lees

Publication details



About this publication

Related content